Post by
Jackal23 on Oct 15, 2020 8:08am
New Financing
Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and performance, announces that given the recent significant ramp up in placed orders for its OxC-beta Livestock™ and the upcoming launch of its human nutraceutical product, it has obtained additional debt financing of $500,000 through an unsecured Promissory Note from a Canadian Financial Institution. The note is payable on demand and bears interest at 12% per annum. The funds will be used to support ongoing general operating activities which include, but are not limited to, the ramp up in inventory in support of increasing frequency and size of orders for OxC-beta Livestock™.
Comment by
DrJayser on Oct 15, 2020 8:28am
I told you the bank account was running on fumes! 12% , 500k$ a real testament that Avivagen is a fortress of strenght!
Comment by
DrJayser on Oct 15, 2020 9:19am
you care about dilution now ????? You stated that you were happy to wait. You have been wrong wrong and wrong again
Comment by
DrJayser on Oct 15, 2020 10:16am
it surely will sell of the charts, like Vivamune with Cesar Milan
Comment by
DrJayser on Oct 15, 2020 10:36am
another 500k$ on top of the 600k$ due + the 3.8M$ long term debt ,it sure adds up! for a company that had 360K$ in gross profit for 9 months! how in the world will they make it?
Comment by
DrJayser on Oct 15, 2020 1:51pm
No Joke, I will order a bottle of OxCB, test it. see if it works!
Comment by
DrJayser on Oct 16, 2020 11:40am
I bet OXCB for humans works, I've seen Pics of The CEO, he doesnt suffer from malnutrition, I'll leave it at that!